These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27194194)

  • 21. Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission.
    Niikura K; Narita M; Butelman ER; Kreek MJ; Suzuki T
    Trends Pharmacol Sci; 2010 Jul; 31(7):299-305. PubMed ID: 20471111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
    Zhao M; Wang JY; Jia H; Tang JS
    Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kappa-opioid receptor: molecular structure and function].
    Spasov AA; Grechko OIu; Shtareva DM
    Eksp Klin Farmakol; 2014; 77(11):27-35. PubMed ID: 25668945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction.
    Kim WM; Jeong CW; Lee SH; Kim YO; Cui JH; Yoon MH
    Anesth Analg; 2011 Oct; 113(4):934-40. PubMed ID: 21788320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced antinociceptive responsiveness to hyperbaric oxygen in opioid-tolerant mice.
    Zhang Y; Stolz PA; Shirachi DY; Quock RM
    Eur J Pain; 2014 Aug; 18(7):1032-9. PubMed ID: 24390852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.
    Pan ZZ; Tershner SA; Fields HL
    Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. δ-Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+ -activated Cl- channels.
    Pacheco Dda F; Pacheco CM; Duarte ID
    J Pharm Pharmacol; 2012 Aug; 64(8):1084-9. PubMed ID: 22775211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches to improve pain relief while minimizing opioid abuse liability.
    Webster LR; Fine PG
    J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concepts in opioid analgesia.
    Stein C
    Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment.
    Johnson EE; Christie MJ; Connor M
    Neurosignals; 2005; 14(6):290-302. PubMed ID: 16772732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation.
    Burton MB; Gebhart GF
    J Pharmacol Exp Ther; 1998 May; 285(2):707-15. PubMed ID: 9580617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to avoid opioid tolerance].
    Brinkschmidt T; Neumeier S
    MMW Fortschr Med; 2011 Sep; 153(36):46-8. PubMed ID: 21932644
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives on cannabis as a substitute for opioid analgesics.
    Khan SP; Pickens TA; Berlau DJ
    Pain Manag; 2019 Mar; 9(2):191-203. PubMed ID: 30681029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.